RUNX Proteins as Epigenetic Modulators in Cancer

Cells. 2022 Nov 20;11(22):3687. doi: 10.3390/cells11223687.

Abstract

RUNX proteins are highly conserved in metazoans and perform critical functions during development. Dysregulation of RUNX proteins through various molecular mechanisms facilitates the development and progression of various cancers, where different RUNX proteins show tumor type-specific functions and regulate different aspects of tumorigenesis by cross-talking with different signaling pathways such as Wnt, TGF-β, and Hippo. Molecularly, they could serve as transcription factors (TFs) to activate their direct target genes or interact with many other TFs to modulate chromatin architecture globally. Here, we review the current knowledge on the functions and regulations of RUNX proteins in different cancer types and highlight their potential role as epigenetic modulators in cancer.

Keywords: RUNX family; cancer; epigenetic modulator; function; regulation.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Core Binding Factor alpha Subunits* / genetics
  • Core Binding Factor alpha Subunits* / metabolism
  • Epigenesis, Genetic
  • Epigenomics
  • Humans
  • Neoplasms* / metabolism
  • Transcription Factors / genetics
  • Transcription Factors / metabolism

Substances

  • Core Binding Factor alpha Subunits
  • Transcription Factors

Grants and funding

This work was funded by Shenzhen Key Laboratory of Gene Regulation and Systems Biology (Grant No. ZDSYS20200811144002008), Shenzhen Science and Technology Program (Grant No. KQTD20180411143432337 and JCYJ20190809154407564).